September 25, 2026
University of Cincinnati hematology researcher Jahnavi Gollamudi, MD, has received new grant funding to study how inflammation predicts bone complications in people with sickle cell disease, offering new hope for treatment.
September 23, 2026
A University of Cincinnati-led study published in the journal Neurology found that strokes among adults ages 20 to 54 nearly doubled over almost three decades, even as short-term survival after stroke improved.
September 22, 2026
From new mentorship honors to a growing research pipeline, see how the University of Cincinnati College of Medicine's graduate programs made this a standout year.
September 25, 2026
University of Cincinnati hematology researcher Jahnavi Gollamudi, MD, has received new grant funding to study how inflammation predicts bone complications in people with sickle cell disease, offering new hope for treatment.
September 23, 2026
A University of Cincinnati-led study published in the journal Neurology found that strokes among adults ages 20 to 54 nearly doubled over almost three decades, even as short-term survival after stroke improved.
September 22, 2026
From new mentorship honors to a growing research pipeline, see how the University of Cincinnati College of Medicine's graduate programs made this a standout year.
September 22, 2026
UC Pediatrics chair Tina Cheng, MD, has received the American Academy of Pediatrics' highest honor for her decades of advancing child health.
September 18, 2026
September is dedicated to raising awareness of several serious diseases, including sickle cell disease and childhood cancer. For patients in Greater Cincinnati fighting these diseases, awareness is only part of the equation. They also need lifesaving blood products.
September 18, 2026
A University of Cincinnati emergency medicine quality improvement campaign avoids 3,500-plus head and cervical spine CT scans, saving $6.2 million in patient charges, more than 14,000 hours of waiting time and significant radiation exposure with no patient harm.
September 14, 2026
Cleveland.com highlighted a University of Cincinnati initiative approved for funding by the Patient-Centered Outcomes Research Institute (PCORI) to expand the implementation of healthy lifestyle interventions and metformin prescription to help manage weight gain in overweight or obese youth taking second-generation antipsychotic medications.
September 14, 2026
The University of Cincinnati is part of Ohio’s $18 million Behavioral Health Scholarship Program, offering full in-state tuition to eligible social work, mental health counseling and clinical psychology graduate students who commit to serving underserved Ohio communities after graduation.
September 11, 2026
A University of Cincinnati College of Nursing nurse-midwifery expert explains how the health care you get before pregnancy can shape outcomes for parents and babies alike.
September 9, 2026
The University of Cincinnati recorded its largest enrollment ever in fall 2026 with more than 54,400 students, driven by record first-year enrollment, growth at UC Blue Ash and rising College Credit Plus participation.
September 8, 2026
A year into his role, Kevin Haworth, PhD, reflects on the University of Cincinnati College of Medicine's largest-ever incoming baccalaureate class, first anatomy certificate graduates and a landmark philanthropic gift.
September 3, 2026
Noninvasive tests have emerged as valuable alternatives for diagnosing, staging and monitoring MASLD and MASH, according to a recent MedCentral report.
September 3, 2026
The Next Lives Here Presidential Fellowship supports the recruitment of top doctoral students through competitive funding, mentorship and professional development.
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.